Preventing blood clots after childbirth in women at intermediate risk
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether giving a short course of a daily blood-thinning injection (enoxaparin) after childbirth can safely prevent blood clots in women at intermediate risk. If you qualify, you would receive the injection or a placebo (inactive shot) for up to 5 days while in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who has just given birth (within the last 6 to 36 hours).
- You are at least 18 years old.
- Your healthcare provider has told you that you have an intermediate (moderate) risk for blood clots after childbirth.
- You have never had a blood clot before.
- You were not already receiving blood-thinning injections (like enoxaparin) during pregnancy.
- You do not have any reason that blood thinners would be unsafe for you (like severe kidney disease, bleeding problems, or a past allergic reaction to heparin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a short course of a low-dose blood thinner (heparin) to prevent dangerous blood clots in the legs or lungs after childbirth. It is for women who have certain risk factors that make clots more likely.
This trial tests whether a daily injection of a blood-thinning medicine called enoxaparin (Lovenox) can safely prevent dangerous blood clots in teens who are critically ill in the intensive care unit with an IV line and an infection or inflammation. It may help reduce the risk of blood clots without causing excess bleeding.
This trial tests whether watching an informative video helps women better understand their blood thinner treatment after childbirth. If you qualify, you'll be shown a video and your knowledge will be assessed.
This trial tests if taking aspirin after delivery helps prevent dangerous blood clots in women with certain risk factors. It's for new mothers who have a clotting disorder, were on bed rest, or have multiple other risk factors like high weight or preeclampsia.
This trial compares two blood-thinning medicines (apixaban and enoxaparin) to prevent dangerous blood clots after childbirth. If you are at higher risk for clots but not breastfeeding, you may be able to take part.
This study compares two blood-thinner medicines given after a C-section to see which one works better at preventing dangerous blood clots. It may help women who are at higher risk for clots rest easier right after delivery.
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.